Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline
Novo Nordisk is getting one piece of good news that is easy to count: Wegovy has now passed five million ...
Tag: Novo Nordisk
Novo Nordisk Faces a Harder Sell as Forecasts, Trials and Rivalry All Tighten
Novo Nordisk may have delivered a quarter that looked respectable on paper, but the market’s verdict was harsher. In a ...
Novo Nordisk’s Weekly Insulin Arrives in India as Buyback Buoys Shares Through Pipeline Blip
Novo Nordisk has opened the door to one of the world's fastest-growing diabetes markets with the launch of Awiqli in ...
Novo Nordisk Tests Resistance Near Overbought as Buyback and Oral Wegovy Drive Sentiment
Novo Nordisk closed the week at €43.32, adding 1.29% on Friday alone, as a wave of analyst upgrades and a ...
Novo Nordisk Deploys Tiered Pricing and Weekly Insulin to Broaden GLP-1 Reach as Medicare Uptake Lags
Medicare Part D prescriptions for Wegovy surged nearly 600 percent within six months of the FDA’s March 2024 cardiovascular risk ...
Novo Nordisk Expands Oral Wegovy to UK and New Liver Indication, Implant Study on Horizon
Novo Nordisk is extending its oral Wegovy franchise across multiple fronts simultaneously, with a UK launch, a fresh liver fibrosis ...
Novo Nordisk Faces a Technical Squeeze as Medicare GLP-1 Plan and Analyst Caucus Diverge
The stock has surged more than 16% over the past month, yet the enthusiasm on Wall Street remains conspicuously muted. ...
Novo Nordisk Faces a Demand Flood as Production Race Nears Critical Juncture
A pair of catalysts is converging on Novo Nordisk just as the Danish drugmaker scrambles to expand its manufacturing footprint. ...
Novo Nordisk’s Share Recovery Picks Up as Legal, Pipeline, and Pill Catalysts Converge
Novo Nordisk’s stock has clawed back more than a third of its losses since the March 2026 trough, closing at ...
Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape
The Danish pharmaceutical heavyweight arrived at the American Diabetes Association congress in New Orleans armed with a double dose of ...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
